Biomedical Systems, a global provider of centralized diagnostic services headquartered in St. Louis, Mo., launches its second generation clinical outcome assessment software offering three platforms to collect patient data. This new electronic patient recorded outcome (ePRO) technology improves patient and investigator user experience, improves patient compliance and expedites study setup by simplifying site tasks and reducing errors.

Biomedical Systems’ electronic clinical outcome assessment (eCOA) technology is used for clinical trials in more than 40 countries in multiple therapeutic areas including respiratory, gastrointestinal, dermatology, oncology and women’s health. Biomedical Systems is the only company providing eCOA technology along with cardiac safety, pulmonary function and imaging centralized diagnostic services.

“The eCOA market is growing fast, and launching this technology enhances our ability to offer centralized diagnostic services,” said Tim Barrett, CEO at Biomedical Systems.

QR code technology is used to reduce investigator burden, improve security and ease the data capture process. With this platform, Biomedical Systems focused on patients’ ease of use by providing new features that improve compliance and worldwide reliable data transmission using the latest telecommunication technologies. In addition, Biomedical Systems relies on a project management team that is key to successful eCOA trials.